These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 703495)

  • 1. [Immunological aspects of acute leukoses].
    Handl S
    Lijec Vjesn; 1978 Jun; 100(6):377. PubMed ID: 703495
    [No Abstract]   [Full Text] [Related]  

  • 2. [HLA system antigens in acute leukoses].
    Dokić M; Popović K; Pejin D; Stefanović N; Belić A; Uzurov V
    Med Pregl; 1984; 37(9-10):379-80. PubMed ID: 6530982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of acute leukoses].
    Krepler P
    Krebsarzt; 1969; 24(4):208-20. PubMed ID: 4190048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some aspects of the disturbances of humoral and cellular immunological barrier in leukemia patients].
    Szmigiel Z
    Przegl Lek; 1973; 30(6):514-7. PubMed ID: 4581660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological markers in acute leukemia and their use in typing and differential diagnosis].
    Mittelman M; Djaldetti M
    Harefuah; 1983 Jun; 104(11-12):513-6. PubMed ID: 6680709
    [No Abstract]   [Full Text] [Related]  

  • 6. [Concurrence of cytochemical and immune patterns of different cell lines in cases of acute leukemia].
    Grignaschi VJ; Pérez Bianco R; Aixalá M; de Tezanos Pinto M
    Medicina (B Aires); 1996; 56(4):339-45. PubMed ID: 9138337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological evaluation of FAB classification of acute leukemia].
    Takiguchi T; Konda S
    Rinsho Ketsueki; 1982 Jul; 23(7):1030-6. PubMed ID: 6958887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute leukoses].
    Geoffroy H; Dufour M; Lacour F
    Maroc Med; 1969 Dec; 49(530):706-25. PubMed ID: 5279502
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological status change in leukemia patients with infectious complications and during immunotherapy].
    Rozanova LM; Smirnova AI; Shcherbakova EG; Zinkovskaia LN; Eremina TN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):18-20. PubMed ID: 7220515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of immunological markers and their correlation with the FAB classification in 100 acute leukemias].
    Carbonell Uberos F; Amigó V; Sanz MA; Riol C; Miravalls C; Pérez Sirvent ML; Gomis F
    Sangre (Barc); 1988 Feb; 33(1):8-11. PubMed ID: 3260044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)].
    Ritter J; Gaedicke G; Winkler K; Landbeck G
    Z Kinderheilkd; 1975 Sep; 120(3):211-5. PubMed ID: 1080934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute leukoses at the Internal Clinic of the Dr. Z. Kucic Hospital in Rjeka].
    Premuzić-Lampic M
    Bilt Hematol Transfuz; 1976; 4(1-2):53-4. PubMed ID: 1066126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of the immunoglobulins and other plasma proteins in acute leukemia studied by immunological methods].
    Díaz-Rubio García E; Díaz-Rubio García M
    Rev Clin Esp; 1973 Mar; 128(6):463-6. PubMed ID: 4633628
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual immunological phenotypes among 104 acute leukemias classified according to the FAB criteria.
    Ferremi P; Franceschini F; Airò P; Rossi G; Marinone G; Cattaneo R
    Haematologica; 1988; 73(6):477-83. PubMed ID: 3148510
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoimmunotherapy for acute nonlymphocytic leukemia with BCG- and/or Nocardia rubra-cell wall skeleton (CWS). II. Analysis of the mechanisms of immunological destruction of the tumor cells.
    Kawano F; Araki K; Eto T; Yoshikawa N; Matsuzaki H; Kishimoto S
    Kumamoto Med J; 1983 Mar; 36(1):29-38. PubMed ID: 6632771
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sphingozine and its natural compounds. 3. Immunological study of synthetic erythro- and threopalmitoyl-lactosylsphingozines (cytolipin H)].
    Milonova TI; Skurkovich SV; Vernberg AIa; Vakulova LA; Samochvalov GI
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):34-6. PubMed ID: 5260237
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological and immunological markers in acute leukaemia (author's transl)].
    López Borrasca A; González M; Hernández F; Ledesma M; Corrales A; San Miguel J
    Sangre (Barc); 1981; 26(5B):756-82. PubMed ID: 6275558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blast-cell bank designated for carrying out immunological studies and immunotherapy of leukemia].
    Bulycheva TI; Leontovich VA; Abezgauz NN; Vonograd-Finkel' FR; Agranenko VA
    Probl Gematol Pereliv Krovi; 1977 Feb; (2):32-5. PubMed ID: 877027
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological study of leukemic cells preserved at ultra-low temperatures].
    Bulycheva TI; Leontovich VA; Abezgauz NN; Samoĭlova RS; Kalinina IA
    Probl Gematol Pereliv Krovi; 1974 Jul; 19(7):29-34. PubMed ID: 4605722
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood cell nucleases in acute and chronic leukoses].
    Gluzman DF; Elenskaia AM; Zinchenko VN; Romanova AF; Butenko ZA
    Probl Gematol Pereliv Krovi; 1972 Aug; 17(8):26-30. PubMed ID: 4510812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.